Xequel Bio, Inc.
CAGE Code: 4GLF5
NCAGE Code: 4GLF5
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 602545654
Summary
Xequel Bio, Inc. is an Active Commercial Supplier with the Cage Code 4GLF5 and is tracked by Dun & Bradstreet under DUNS Number 602545654..
Address
777 Taylor St Ste 1140
Fort Worth TX 76102-4921
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Asquared Enterprises Avis Industries, Inc. E D Audio Visual General Steel Co General Services Administration Texas Greenhouse Company Allgood Products Worth Co Armstrong Distributors Mosites G A Co Pointwise, Inc Gaskade Manufacturing Co. Hancock A V Mfg Co Almar-York Co Inc Exp Pharmaceutical Services Corp. Fort Worth Housing Finance Kmc Machinig And Tool Plastic Packaging Inc Duncan A And Co Made Impact Llc
Frequently Asked Questions (FAQ) for CAGE 4GLF5
- What is CAGE Code 4GLF5?
- 4GLF5 is the unique identifier used by NATO Organizations to reference the physical entity known as Xequel Bio, Inc. located at 777 Taylor St Ste 1140, Fort Worth TX 76102-4921, United States.
- Who is CAGE Code 4GLF5?
- 4GLF5 refers to Xequel Bio, Inc. located at 777 Taylor St Ste 1140, Fort Worth TX 76102-4921, United States.
- Where is CAGE Code 4GLF5 Located?
- CAGE Code 4GLF5 is located in Fort Worth, TX, USA.
Contracting History for CAGE 4GLF5 Most Recent 25 Records
- 75A50121C00030
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 12 Nov 2021
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00030
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 26 May 2022
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00030
- Xequel Bio Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 28 Jul 2023
- Xequel Bio Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00030
- Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 25 Mar 2021
- Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $742,500.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00030
- Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 23 Sep 2021
- Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00030
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- 17 Feb 2023
- Eo14042 Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (Redirect)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 4 Mar 2022
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,343,762.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 16 Sep 2022
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,350,879.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 16 Sep 2022
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $4,350,879.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 15 Oct 2021
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,693,749.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 15 Mar 2021
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,693,749.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 22 Dec 2023
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,482,734.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 8 Jun 2021
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $1,693,749.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 12 Sep 2023
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $6,482,734.00
- Department Of Health And Human Services (Hhs)
- 75N93021C00009
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- 8 Mar 2023
- Granexin As A Topical Therapeutic To Mitigate Cutaneous Radiation Injury
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,982,734.00
- Department Of Health And Human Services (Hhs)
- W81XWH17C0065
- Igf::Ot::Igf Dha Sbir Ph Ii Proposal No. A2-6647
- 20 Sep 2017
- Igf::Ot::Igf Dha Sbir Ph Ii Proposal No. A2-6647
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $999,961.00
- Department Of Defense (Dod)
- W81XWH17C0065
- Mrdc Army Sbir Ph Ii Titled: A Novel Peptide-Based Topical Therapeutic To Promote Corneal Regeneration And Restorethe Phas Corneal Biomechanics Following Blast And Burns
- 25 Jun 2021
- Mrdc Army Sbir Ph Ii Titled: A Novel Peptide-Based Topical Therapeutic To Promote Corneal Regeneration And Restorethe Phas Corneal Biomechanics Following Blast And Burns
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,549,961.00
- Department Of Defense (Dod)
- W81XWH17C0065
- Medical Research And Development Contract Army Sbir Ph Ii A2-6647
- 16 Feb 2022
- Medical Research And Development Contract Army Sbir Ph Ii A2-6647
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,549,960.15
- Department Of Defense (Dod)
- W81XWH17C0065
- Army Medical Research And Development Contract Sbir Ph Ii A2-6647
- 18 Nov 2021
- Army Medical Research And Development Contract Sbir Ph Ii A2-6647
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,549,960.15
- Department Of Defense (Dod)